Analysis of the Toxicity and Efficacy of Daily 1 vs 2 Beam Proton Therapy

Thanks to the intrinsic qualities of the proton beam, proton therapy will reduce adverse effects of irradiation. The Proteus®One is the latest generation of proton therapy equipment, enabling the Centre Antoine Lacassagne to expand its range of treatments by carrying out new proton therapy treatments. It has an innovative compact isocentric rotating head (Gantry) that allows the radiation beam to be directed at different angles around the patient. In some cases, two beams are used to treat tumours, and by convention, both beams are delivered during the same session. However, it is necessary to

Trial Details

NCT ID
NCT06029218
Phase
NA
Sponsor
Centre Antoine Lacassagne
Status
RECRUITING
Cancer Type
Osteosarcoma Sarcoma
Interventions
  • Proteus ONE one daily beam
  • Proteus ONE two daily beam
Locations (sample)
  • Nice, France|43.70313,7.26608

Key Eligibility Criteria

  • Chordoma, chondrosarcoma of the skull base and spine, Ewing's sarcoma, and osteosarcoma meeting the criteria for treatment by proton therapy
  • Tumour requiring 2 beams
  • MRI less than one month old
  • Patient who has read the patient information note and signed the consent form.

For full eligibility, visit ClinicalTrials.gov.

Check If You May Be Eligible

Trialify translates complex eligibility criteria into plain yes-or-no questions to help you understand if this trial might be right for you.

Find Osteosarcoma Sarcoma Trials on Trialify →